Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.

NCT02866214 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Dysfunction
Endstage Renal Disease

Interventions

DRUG: Febuxostat
DRUG: Placebo

Sponsor

Ain Shams University